3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
5
Lymphoma
4
Breast Neoplasms
4
Ovarian Neoplasms
3
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Endometrial Neoplasms
3
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Colonic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid cancer, follicular
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma, Mantle-Cell
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Gemcitabine
15
Cisplatin
15
pembrolizumab
9
Oxaliplatin
7
durvalumab
5
Leucovorin
5
Fluorouracil
5
130-nm albumin-bound paclitaxel
5
Platinum
4
Albumin-Bound Paclitaxel
4
1,2-diaminocyclohexaneplatinum II citrate
4
Trastuzumab
3
Taxes
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Capecitabine
3
zanidatamab
2
fludarabine
2
Paclitaxel
2
Nivolumab
2
Folfox protocol
2
Docetaxel
2
Cyclophosphamide
2
Biopsy
2
tucatinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
tivozanib
1
pertuzumab
1
peposertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
copanlisib
×
1 year
×
Clear all
No trials found.